Marcel Feig
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 8
- Epidemiology 21
- Influenza Virus Research Studies 5
- Virology and Viral Diseases 5
- Urinary Tract Infections Management 4
- Co-authors
- Tim Eckmanns (24 shared papers)Ole Wichmann (10 shared papers)Thorsten Rieck (10 shared papers)Anette Siedler (10 shared papers)Ines Noll (10 shared papers)Annicka Reuß (7 shared papers)Muna Abu Sin (6 shared papers)H. Claus (4 shared papers)
In The Last Decade
Marcel Feig
30 papers receiving 523 citations
Peers
Comparison fields: 5 of 72
- Applied Microbiology and Biotechnology 64
- Molecular Medicine 79
- Health 64
- Epidemiology 244
- Infectious Diseases 113
Countries citing papers authored by Marcel Feig
This map shows the geographic impact of Marcel Feig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Feig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Feig more than expected).
Fields of papers citing papers by Marcel Feig
This network shows the impact of papers produced by Marcel Feig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Feig. The network helps show where Marcel Feig may publish in the future.
Co-authors
The 25 scholars most cited alongside Marcel Feig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 59 | |
| 2 | 2021 | 50 | |
| 3 | 2017 | 40 | |
| 4 | 2018 | 34 | |
| 5 | 2018 | 33 | |
| 6 | 2014 | 32 | |
| 7 | 2017 | 31 | |
| 8 | 2012 | 26 | |
| 9 | 2018 | 26 | |
| 10 | 2010 | 23 | |
| 11 | 2010 | 21 | |
| 12 | 2020 | 20 | |
| 13 | 2011 | 18 | |
| 14 | 2020 | 17 | |
| 15 | 2021 | 14 | |
| 16 | 2022 | 13 | |
| 17 | 2011 | 12 | |
| 18 | 2021 | 12 | |
| 19 | 2010 | 11 | |
| 20 | [MRSA and ESBL in outpatient: development from 2008 up to 2012 and socio demographic differences]. | 2015 | 10 |
About Marcel Feig
Marcel Feig is a scholar working on Applied Microbiology and Biotechnology, Epidemiology, Health, Infectious Diseases and Molecular Medicine, having authored 34 papers that have together received 544 indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (9 papers), Antibiotic Use and Resistance (8 papers), Influenza Virus Research Studies (5 papers), Virology and Viral Diseases (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Urinary Tract Infections Management (4 papers), Antibiotic Resistance in Bacteria (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (64 citations), Molecular Medicine (79 citations), Health (64 citations), Epidemiology (244 citations) and Infectious Diseases (113 citations). Marcel Feig has collaborated with scholars based in Germany, Sweden and Belgium. Frequent co-authors include Tim Eckmanns, Ole Wichmann, Thorsten Rieck, Anette Siedler, Ines Noll, Annicka Reuß, Muna Abu Sin, H. Claus, Niklas Willrich and Gabriele Poggensee. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Resistance and Infection Control, PLoS ONE, Vaccine and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.